Company intelligence / Profile preview

3D Global Biotech

New Taipei City, Taiwan

Ownership: Private
Employees: ~25
Development stage: Other

Overview

3D Global Biotech is commercializing several medical device products for tissue, bone, and dental reconstruction, utilizing proprietary 3D bioprinting platforms, hydrogel bio-inks, and cell-based technologies. Products include FDA-approved bone graft substitutes and next-generation soft tissue scaffolds, with notable regulatory and industrial recognition in Asia. Recent recognitions include Thai FDA approval (2024), and multiple industry awards[5].

Therapeutic areas: OtherNeurologyOphthalmologyRheumatology
Modalities: Cell therapyHydrogel-based drug delivery therapyBiologicMedical device
Industry: Implantable Medical Devices

Partnerships

TMU - Research Center for Biomedical Devices and Prototyping Production

Beyond the preview

Go deeper on 3D Global Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3D Global Biotech.

Explore the full profile